Publication Information

{'id': 'https://openalex.org/W2040400838', 'doi': 'https://doi.org/10.1021/jm0255522', 'title': 'Structure−Activity Relationship of (1-Aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/Melanocortin Receptor Binding', 'display_name': 'Structure−Activity Relationship of (1-Aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/Melanocortin Receptor Binding', 'publication_year': 2002, 'publication_date': '2002-11-27', 'ids': {'openalex': 'https://openalex.org/W2040400838', 'doi': 'https://doi.org/10.1021/jm0255522', 'mag': '2040400838', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12502354'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm0255522', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5036770247', 'display_name': 'Premilla N. Arasasingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Premilla N. Arasasingham', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083366030', 'display_name': 'Christopher Fotsch', 'orcid': 'https://orcid.org/0009-0000-8177-390X'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher Fotsch', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087596533', 'display_name': 'Xiaohu Ouyang', 'orcid': 'https://orcid.org/0000-0003-1600-0251'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xiaohu Ouyang', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049963981', 'display_name': 'Mark H. Norman', 'orcid': 'https://orcid.org/0009-0002-4399-5493'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark H. Norman', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083159861', 'display_name': 'Michael Kelly', 'orcid': 'https://orcid.org/0000-0001-7955-3860'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael G. Kelly', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024804968', 'display_name': 'Kevin L. Stark', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin L. Stark', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019231762', 'display_name': 'Bill Karbon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bill Karbon', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042070146', 'display_name': 'Clarence Hale', 'orcid': 'https://orcid.org/0000-0001-9670-3330'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Clarence Hale', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063120373', 'display_name': 'James W. Baumgartner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James W. Baumgartner', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108295285', 'display_name': 'Martha Zambrano', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Martha Zambrano', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109979480', 'display_name': 'Janet Cheetham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Janet Cheetham', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5010906992', 'display_name': 'Nuria Tamayo', 'orcid': 'https://orcid.org/0000-0002-0497-5230'}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nuria A. Tamayo', 'raw_affiliation_strings': ['Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799'], 'affiliations': [{'raw_affiliation_string': 'Departments of Small Molecule Drug Discovery and Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799', 'institution_ids': ['https://openalex.org/I1320553840']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.704, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 42, 'citation_normalized_percentile': {'value': 0.543707, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '46', 'issue': '1', 'first_page': '9', 'last_page': '11'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10489', 'display_name': 'Regulation of Appetite and Obesity', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2807', 'display_name': 'Endocrine and Autonomic Systems'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10489', 'display_name': 'Regulation of Appetite and Obesity', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2807', 'display_name': 'Endocrine and Autonomic Systems'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11584', 'display_name': 'Biochemical Analysis and Sensing Techniques', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2916', 'display_name': 'Nutrition and Dietetics'}, 'field': {'id': 'https://openalex.org/fields/29', 'display_name': 'Nursing'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11144', 'display_name': 'melanin and skin pigmentation', 'score': 0.9958, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/orexigenic', 'display_name': 'Orexigenic', 'score': 0.8682761}, {'id': 'https://openalex.org/keywords/melanocortin-4-receptor', 'display_name': 'Melanocortin 4 receptor', 'score': 0.849141}, {'id': 'https://openalex.org/keywords/melanocortin-3-receptor', 'display_name': 'Melanocortin 3 receptor', 'score': 0.8044338}], 'concepts': [{'id': 'https://openalex.org/C2779993316', 'wikidata': 'https://www.wikidata.org/wiki/Q6591465', 'display_name': 'Melanocortin', 'level': 3, 'score': 0.88973933}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.87667453}, {'id': 'https://openalex.org/C2777205416', 'wikidata': 'https://www.wikidata.org/wiki/Q433807', 'display_name': 'Orexigenic', 'level': 5, 'score': 0.8682761}, {'id': 'https://openalex.org/C43295716', 'wikidata': 'https://www.wikidata.org/wiki/Q21118676', 'display_name': 'Melanocortin 4 receptor', 'level': 4, 'score': 0.849141}, {'id': 'https://openalex.org/C43790157', 'wikidata': 'https://www.wikidata.org/wiki/Q21118678', 'display_name': 'Melanocortin 3 receptor', 'level': 5, 'score': 0.8044338}, {'id': 'https://openalex.org/C2777241137', 'wikidata': 'https://www.wikidata.org/wiki/Q24784850', 'display_name': 'Melanocortin receptor', 'level': 4, 'score': 0.66146517}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.5905251}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.58046144}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.56638676}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.55425984}, {'id': 'https://openalex.org/C16613235', 'wikidata': 'https://www.wikidata.org/wiki/Q285982', 'display_name': 'Endogeny', 'level': 2, 'score': 0.44037807}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34717175}, {'id': 'https://openalex.org/C118303440', 'wikidata': 'https://www.wikidata.org/wiki/Q419968', 'display_name': 'Neuropeptide', 'level': 3, 'score': 0.24988207}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.22625697}, {'id': 'https://openalex.org/C93984277', 'wikidata': 'https://www.wikidata.org/wiki/Q24782073', 'display_name': 'Neuropeptide Y receptor', 'level': 4, 'score': 0.14864686}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.066446245}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D011506', 'descriptor_name': 'Proteins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D018043', 'descriptor_name': 'Receptors, Corticotropin', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D054369', 'descriptor_name': 'Agouti-Related Protein', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001665', 'descriptor_name': 'Binding Sites', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D036341', 'descriptor_name': 'Intercellular Signaling Peptides and Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011506', 'descriptor_name': 'Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011506', 'descriptor_name': 'Proteins', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D044105', 'descriptor_name': 'Receptor, Melanocortin, Type 4', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018043', 'descriptor_name': 'Receptors, Corticotropin', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D018043', 'descriptor_name': 'Receptors, Corticotropin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000521', 'descriptor_name': 'alpha-MSH', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D000521', 'descriptor_name': 'alpha-MSH', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000521', 'descriptor_name': 'alpha-MSH', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm0255522', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12502354', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 12, 'referenced_works': ['https://openalex.org/W1577992062', 'https://openalex.org/W1964866401', 'https://openalex.org/W1972455073', 'https://openalex.org/W2034801992', 'https://openalex.org/W2049848270', 'https://openalex.org/W2075420089', 'https://openalex.org/W2095417482', 'https://openalex.org/W2097493897', 'https://openalex.org/W2105470099', 'https://openalex.org/W2144143345', 'https://openalex.org/W2171010063', 'https://openalex.org/W4240225536'], 'related_works': ['https://openalex.org/W2159015722', 'https://openalex.org/W2095417482', 'https://openalex.org/W2077883898', 'https://openalex.org/W2049553716', 'https://openalex.org/W2040364475', 'https://openalex.org/W2036250760', 'https://openalex.org/W2028646384', 'https://openalex.org/W2016796573', 'https://openalex.org/W2015451996', 'https://openalex.org/W1973541680'], 'abstract_inverted_index': {'Agouti-related': [0], 'protein': [1], '(AGRP)': [2], 'is': [3, 32], 'an': [4, 33], 'endogenous': [5], 'antagonist': [6], 'of': [7, 39], 'the': [8, 12, 26, 40], 'melanocortin': [9, 14], 'action.1': [10], 'In': [11], 'hypothalamus,': [13], 'peptide': [15], 'agonists': [16], 'act': [17], 'as': [18], 'satiety-inducing': [19], 'factors': [20], 'that': [21], 'mediate': [22], 'their': [23, 49], 'action': [24], 'through': [25], 'melanocortin-4': [27], 'receptor': [28], '(MC4R)': [29], 'whereas': [30], 'AGRP': [31], 'opposing': [34], 'orexigenic': [35], 'agent.': [36], 'Novel': [37], 'inhibitors': [38], 'AGRP/MC4': [41], 'binding': [42], 'based': [43], 'on': [44], '(piperazinylethyl)piperazines': [45], 'were': [46], 'prepared,': [47], 'and': [48], 'structure−activity': [50], 'relationship': [51], 'was': [52], 'established.': [53]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2040400838', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2025-01-11T10:41:12.106756', 'created_date': '2016-06-24'}